Bioventus Inc. provided earnings guidance for the year 2024. For the year, the company expects net sales to be in the range of $520 million to $535 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.6 USD | +2.19% |
|
-3.78% | +6.26% |
05-07 | Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024 | CI |
05-07 | Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.26% | 357M | |
+75.69% | 12.57B | |
+12.50% | 7B | |
-30.50% | 6.78B | |
+9.11% | 5.2B | |
-20.06% | 4.67B | |
+19.81% | 4.26B | |
-21.04% | 3.84B | |
-28.39% | 2.7B | |
-1.73% | 1.98B |
- Stock Market
- Equities
- BVS Stock
- News Bioventus Inc.
- Bioventus Inc. Provides Earnings Guidance for the Year 2024